Instil Bio, Inc. Depreciation
Instil Bio, Inc. (TIL) reported Depreciation of $200.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-13
- Instil Bio, Inc. depreciation for the quarter ending 2026-06-30 was $200.00K.
- Instil Bio, Inc. depreciation for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Instil Bio, Inc. depreciation for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Instil Bio, Inc. depreciation for the quarter ending 2025-09-30 was $10.00K, a 98.89% decline year-over-year.
- Instil Bio, Inc. depreciation for fiscal 2025 was $500.00K, a 86.11% decline from fiscal 2024.
- Instil Bio, Inc. depreciation for fiscal 2024 was $3.60M, a 25.00% decline from fiscal 2023.
- Instil Bio, Inc. depreciation for fiscal 2023 was $4.80M, a 20.00% decline from fiscal 2022.
- Instil Bio, Inc. depreciation for fiscal 2022 was $6.00M, a 122.22% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-13 | $300.00K 10-Q · filed 2026-08-13 | $200.00K derived: sum of 3 quarters · filed 2026-08-13 | $210.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $10.00K derived: sum of 3 quarters · filed 2026-05-15 | $10.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $10.00K derived: sum of 2 quarters · filed 2026-03-27 | $10.00K derived: sum of 3 quarters · filed 2026-08-13 | $500.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $10.00K 10-Q · filed 2025-11-13 | $10.00K derived: sum of 2 quarters · filed 2026-08-13 | $500.00K 10-Q · filed 2025-11-13 | $1.21M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $500.00K 10-Q · filed 2026-08-13 | $1.20M derived: sum of 3 quarters · filed 2026-08-13 | $2.10M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $500.00K 10-Q · filed 2026-05-15 | $1.20M derived: sum of 2 quarters · filed 2026-05-15 | $2.10M derived: sum of 3 quarters · filed 2026-05-15 | $3.10M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.60M derived: sum of 2 quarters · filed 2026-03-27 | $2.60M derived: sum of 3 quarters · filed 2026-03-27 | $3.60M 10-K · filed 2026-03-27 |
| 2024-09-30 | $900.00K 10-Q · filed 2025-11-13 | $1.90M derived: sum of 2 quarters · filed 2025-11-13 | $2.90M 10-Q · filed 2025-11-13 | $4.00M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $1.00M 10-Q · filed 2025-08-13 | $2.00M 10-Q · filed 2025-08-13 | $3.10M derived: sum of 3 quarters · filed 2025-08-13 | $4.10M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $1.00M 10-Q · filed 2025-05-13 | $2.10M derived: sum of 2 quarters · filed 2025-05-13 | $3.10M derived: sum of 3 quarters · filed 2025-05-13 | $4.10M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $2.10M derived: sum of 2 quarters · filed 2025-03-04 | $3.10M derived: sum of 3 quarters · filed 2025-03-04 | $4.80M 10-K · filed 2025-03-04 |
| 2023-09-30 | $1.00M 10-Q · filed 2024-11-13 | $2.00M derived: sum of 2 quarters · filed 2024-11-13 | $3.70M 10-Q · filed 2024-11-13 | $5.90M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $1.00M 10-Q · filed 2024-08-13 | $2.80M 10-Q · filed 2024-08-13 | $4.90M derived: sum of 3 quarters · filed 2024-08-13 | $6.80M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.80M 10-Q · filed 2024-05-10 | $3.90M derived: sum of 2 quarters · filed 2024-05-10 | $5.80M derived: sum of 3 quarters · filed 2024-05-10 | $6.80M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $4.00M derived: sum of 2 quarters · filed 2024-03-21 | $5.00M derived: sum of 3 quarters · filed 2024-03-21 | $6.00M 10-K · filed 2024-03-21 |
| 2022-09-30 | $1.90M 10-Q · filed 2023-11-13 | $2.90M derived: sum of 2 quarters · filed 2023-11-13 | $3.90M 10-Q · filed 2023-11-13 | $4.60M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.00M 10-Q · filed 2023-08-14 | $1.90M 10-Q · filed 2023-08-14 | $2.70M derived: sum of 3 quarters · filed 2023-08-14 | $3.50M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $900.00K 10-Q · filed 2023-05-11 | $1.70M derived: sum of 2 quarters · filed 2023-05-11 | $2.50M derived: sum of 3 quarters · filed 2023-05-11 | $3.20M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.60M derived: sum of 2 quarters · filed 2023-03-31 | $2.30M derived: sum of 3 quarters · filed 2023-03-31 | $2.70M 10-K · filed 2023-03-31 |
| 2021-09-30 | $800.00K 10-Q · filed 2022-11-14 | $1.50M derived: sum of 2 quarters · filed 2022-11-14 | $1.90M 10-Q · filed 2022-11-14 | $2.20M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $700.00K 10-Q · filed 2022-08-12 | $1.10M 10-Q · filed 2022-08-12 | $1.40M derived: sum of 3 quarters · filed 2022-08-12 | $1.40M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $400.00K 10-Q · filed 2022-05-16 | $700.00K derived: sum of 2 quarters · filed 2022-05-16 | $700.00K derived: sum of 3 quarters · filed 2022-05-16 | $700.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $300.00K derived: sum of 2 quarters · filed 2022-03-07 | $300.00K derived: sum of 3 quarters · filed 2022-03-07 | $300.00K 10-K · filed 2022-03-07 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |